181 related articles for article (PubMed ID: 19203505)
1. Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution.
Glezerman I; Kris MG; Miller V; Seshan S; Flombaum CD
Clin Nephrol; 2009 Feb; 71(2):130-9. PubMed ID: 19203505
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
Saif MW; McGee PJ
JOP; 2005 Jul; 6(4):369-74. PubMed ID: 16006690
[TBL] [Abstract][Full Text] [Related]
3. [Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature].
Desramé J; Duvic C; Bredin C; Béchade D; Artru P; Brézault C; Defuentes G; Poirier JM; Dourthe LM; Coutant G; Chaussade S; de Gramont A; Algayres JP
Rev Med Interne; 2005 Mar; 26(3):179-88. PubMed ID: 15777580
[TBL] [Abstract][Full Text] [Related]
4. [Hemolytic-uremic syndrome associated with gemcitabine use: report of one case].
Vega J; Parodi C; Méndez GP; Goecke H
Rev Med Chil; 2013 Jun; 141(6):797-802. PubMed ID: 24121585
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
[TBL] [Abstract][Full Text] [Related]
6. [Hemolytic uremic syndrome induced by gemcitabine. A poorly recognized complication?].
Graas MP; Houbiers G; Demolin G; Stultiens A; Focan C
Rev Med Liege; 2012 Dec; 67(12):644-8. PubMed ID: 23342875
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports
.
López Rubio ME; Rodado Martínez R; Illescas ML; Mateo Bosch E; Martinez Díaz M; de la Vara Inesta L; Cabezuelo B; Morales Albuja ME; Lucas Guillén E; Jimeno García L
Clin Nephrol; 2017 Feb; 87 (2017)(2):100-106. PubMed ID: 27879189
[TBL] [Abstract][Full Text] [Related]
8. [A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine].
Eckel F; Lersch C; Erdmann J; Schmidt B; Schulte-Frohlinde E
Z Gastroenterol; 2000 Jul; 38(7):593-6. PubMed ID: 10965557
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic-uremic syndrome complicating a long-term treatment with gemcitabine. Report of a case and review of the literature].
Dilhuydy MS; Delclaux C; Pariente A; De Precigout V; Aparicio M
Rev Med Interne; 2002 Feb; 23(2):189-92. PubMed ID: 11876063
[TBL] [Abstract][Full Text] [Related]
10. [Hemolytic uremic syndrome following gemcitabine treatment].
Bourquin V; Guinand A; Haenni C; Giovannini M; Delouche D; Dettwiler S; Moll S
Rev Med Suisse; 2008 Apr; 4(154):1056-61. PubMed ID: 18557535
[TBL] [Abstract][Full Text] [Related]
11. [A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer].
Wato M; Inaba T; Ishikawa H; Ishikawa S; Baba N; Miyoshi M; Senoh T; Nagano T; Takaguchi K; Watanabe S; Kawai K
Nihon Shokakibyo Gakkai Zasshi; 2010 Oct; 107(10):1676-85. PubMed ID: 20938119
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma.
Nieto-Ríos JF; Zuluaga-Quintero M; Higuita LM; Rincón CI; Galvez-Cárdenas KM; Ocampo-Kohn C; Aristizabal-Alzate A; Florez-Vargas AA; Zuluaga-Valencia GA
J Bras Nefrol; 2016 Jun; 38(2):255-9. PubMed ID: 27438981
[TBL] [Abstract][Full Text] [Related]
13. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution.
Müller S; Schütt P; Bojko P; Nowrousian MR; Hense J; Seeber S; Moritz T
Ann Hematol; 2005 Feb; 84(2):110-4. PubMed ID: 15340761
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Held-Warmkessel J
Oncol Nurs Forum; 2014 Sep; 41(5):551-3. PubMed ID: 25158661
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine-associated thrombotic microangiopathy.
Humphreys BD; Sharman JP; Henderson JM; Clark JW; Marks PW; Rennke HG; Zhu AX; Magee CC
Cancer; 2004 Jun; 100(12):2664-70. PubMed ID: 15197810
[TBL] [Abstract][Full Text] [Related]
16. The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
Krishnappa V; Gupta M; Shah H; Das A; Tanphaichitr N; Novak R; Raina R
BMC Nephrol; 2018 Jan; 19(1):9. PubMed ID: 29329518
[TBL] [Abstract][Full Text] [Related]
17. Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab.
Gourley BL; Mesa H; Gupta P
Cancer Chemother Pharmacol; 2010 Apr; 65(5):1001-4. PubMed ID: 20119714
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine.
Vénat-Bouvet L; Ly K; Szelag JC; Martin J; Labourey JL; Genet D; Tubiana-Mathieu N
Anticancer Drugs; 2003 Nov; 14(10):829-32. PubMed ID: 14597878
[TBL] [Abstract][Full Text] [Related]
19. Is therapeutic plasma exchange indicated for patients with gemcitabine-induced hemolytic uremic syndrome?
Gore EM; Jones BS; Marques MB
J Clin Apher; 2009; 24(5):209-14. PubMed ID: 19816959
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
Flombaum CD; Mouradian JA; Casper ES; Erlandson RA; Benedetti F
Am J Kidney Dis; 1999 Mar; 33(3):555-62. PubMed ID: 10070921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
